SKI Market

Indian Indices

Nifty

25,108.30 30.65
(0.12%)

Sensex

81,803.55 -123.20
( -0.15%)

Bank Nifty

56,239.35 134.50
( 0.24%)

Nifty IT

34,709.45 -13.05
( -0.04%)

Global Indices

Nasdaq

46,617.06 -98.92
(-0.21%)

Dow Jones

6,734.42 -26.86
(-0.40%)

Hang Seng

48,001.68 56.92
(0.12%)

Nikkei 225

9,483.58 4.44
(0.05%)

Forex

USD-INR

88.74 0.02
(0.02%)

EUR-INR

103.85 -0.31
(-0.30%)

GBP-INR

119.42 -0.10
(-0.08%)

JPY-INR

0.59 -0.01
(-1.59%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

533573

INE901L01018

264.278595

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

APLLTD

42.97

18040.56

EPS(TTM)

Face Value()

Div & Yield %

21.36

1.2

Back

Ardi Investments & Trading Company reports standalone net loss of Rs 0.02 crore in the June 2025 quarter

Aug 12,2025

Net loss of Ardi Investments & Trading Company reported to Rs 0.02 crore in the quarter ended June 2025 as against net profit of Rs 0.67 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 as against Rs 4.11 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	0	4.11	-100
OPM %	0	21.65	-
PBDT	-0.02	0.91	PL
PBT	-0.02	0.91	PL
NP	-0.02	0.67	PL

25,108.30 30.65 (0.12%)

81,803.55 -123.20 ( -0.15%)

56,239.35 134.50 ( 0.24%)

34,709.45 -13.05 ( -0.04%)

46,617.06 -98.92 (-0.21%)

6,734.42 -26.86 (-0.40%)

48,001.68 56.92 (0.12%)

9,483.58 4.44 (0.05%)

88.74 0.02 (0.02%)

103.85 -0.31 (-0.30%)

119.42 -0.10 (-0.08%)

0.59 -0.01 (-1.59%)